Document Detail


Natural history and predictors of outcome in patients with concomitant functional mitral regurgitation at the time of aortic valve replacement.
MedLine Citation:
PMID:  16820634     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
BACKGROUND: Concomitant functional mitral regurgitation (FMR) in patients undergoing aortic valve replacement (AVR) is frequently not corrected because it may improve after AVR; however, data supporting this assumption are sparse. We ascertained the impact of clinical and echocardiographic parameters on the outcome of patients with or without concomitant FMR at the time of AVR. METHODS AND RESULTS: Clinical and echocardiographic follow-up was performed on 848 patients who underwent AVR after 1990. Risk factors for mortality and a composite outcome of heart failure (CHF) symptoms, CHF death, or subsequent mitral repair or replacement, were examined with bootstrapped Cox proportional hazard models. Follow-up was 4591 patient-years (mean 5.4+/-3.4 years; maximum 14.2 years). FMR > or = 2+ had no independent adverse effect on survival in patients with aortic stenosis (AS) or insufficiency (AI). However, AS patients with FMR > or = 2+ and 1 additional risk factor (left atrial diameter >5 cm, preoperative peak aortic valve gradient <60 mm Hg, or atrial fibrillation) were at increased risk for the composite outcome (hazard ratio [HR]: 2.7; P=0.004). AI patients with FMR > or = 2+ and a left ventricular end-systolic diameter <45 mm were also at risk (HR: 4.0; P=0.02). Clinical risk factors in the AS and AI subgroups were associated with an increased likelihood of mitral regurgitation > or = 2+ at 18 months postoperatively. CONCLUSIONS: AS patients with FMR > or = 2+ and a left atrial diameter >5 cm, preoperative peak aortic valve gradient <60 mm Hg, or atrial fibrillation have a significantly higher risk of CHF and persistent mitral regurgitation after AVR than other AS patients. AI patients with FMR > or = 2+ and a left ventricular end-systolic diameter <45 mm preoperatively are also at increased risk. Others fare well after AVR.
Authors:
Marc Ruel; Varun Kapila; Joel Price; Alexander Kulik; Ian G Burwash; Thierry G Mesana
Related Documents :
9509684 - Primary hyperparathyroidism with cardiac abnormalities: a case report.
18317804 - Resolution of pathologic q wave, left ventricular dysfunction and mitral regurgitation ...
17167384 - Functional mitral regurgitation and chronic heart failure.
17584194 - A new echocardiographic index for assessing left ventricular function and mechanism of ...
22701134 - Clinical impact of non-high density lipoprotein-cholesterol and apolipoprotein b on cli...
24275554 - Growth/differentiation factor 1 alleviates pressure overload-induced cardiac hypertroph...
Publication Detail:
Type:  Comparative Study; Journal Article    
Journal Detail:
Title:  Circulation     Volume:  114     ISSN:  1524-4539     ISO Abbreviation:  Circulation     Publication Date:  2006 Jul 
Date Detail:
Created Date:  2006-07-05     Completed Date:  2006-08-18     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  0147763     Medline TA:  Circulation     Country:  United States    
Other Details:
Languages:  eng     Pagination:  I541-6     Citation Subset:  AIM; IM    
Affiliation:
Division of Cardiac Surgery, University of Ottawa, Ottawa, Ontario, Canada. mruel@ottawaheart.ca
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Aged
Aortic Valve / surgery*
Aortic Valve Insufficiency / complications,  epidemiology,  surgery*
Aortic Valve Stenosis / complications,  epidemiology,  surgery*
Atrial Fibrillation / epidemiology,  etiology
Cohort Studies
Coronary Disease / complications,  epidemiology
Female
Follow-Up Studies
Heart Failure / epidemiology*,  etiology
Heart Valve Prosthesis Implantation*
Humans
Incidence
Male
Middle Aged
Mitral Valve Insufficiency / complications,  epidemiology*,  surgery
Mortality
Postoperative Complications / epidemiology
Proportional Hazards Models
Risk Factors
Stroke Volume
Survival Analysis
Treatment Outcome

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Are stentless valves superior to modern stented valves? A prospective randomized trial.
Next Document:  Role of human valve interstitial cells in valve calcification and their response to atorvastatin.